Obiettivo The project addresses the problem of bone defect treatment. Using a marine alga ashydroxyapatite (HA) source, we aim to produce a fully biodegradable, bone growth-enhancing product, which can be used in any part of the skeleton to restore fully functional bones. This implant will be complete resorted and replaced by patients own, newly grown bone after a maximal period of 10 month, depending on the size of the implant. The main objectives are: - Cultivating the alga to ensure a permanent and high quality supply- Standardise the transformation process and develop a compacted form for more complicated areas- Integrate the HA in a carrier to simplify the application- Enrich the HA/carrier complex with bone growth factor and other medicines for long term release Prototype products will be tested on animals and humans equally, after ethical and legal considerations. Campo scientifico natural sciencesbiological sciencesmicrobiologyphycologymedical and health sciencesmedical biotechnologyimplantsartificial bone Programma(i) FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002 Argomento(i) 1.1.1.-5. - Key action Sustainable Agriculture, Fisheries and Forestry Invito a presentare proposte Data not available Meccanismo di finanziamento EAW - Exploratory awards Coordinatore N/A Contributo UE Nessun dato Indirizzo Mostra sulla mappa Costo totale Nessun dato Partecipanti (1) Classifica in ordine alfabetico Classifica per Contributo UE Espandi tutto Riduci tutto DOLPHIN SEA VEGETABLE COMPANY Regno Unito Contributo UE Nessun dato Indirizzo Glenwood business Centre UNIT 54, Sprinbank Indust BT17 0QL Dunmury - Belfast Mostra sulla mappa Costo totale Nessun dato